So far we have demonstrated that DTX‐mediated Treg depletion in tumor bearing BALB/c FoxP3.dtr mice is associated with significant increases in CD8 and CD4 T cell activation and an overall survival benefit, compared to untreated controls. This evidence concerns the gene CD8A and neoplasm.